Research Links Immune Cell Receptors to Asthma, Inflammatory Lung Disease

A Cleveland Clinic research team has discovered how a protein on the surface of immune system mast cells in the lungs facilitates the cells’ proliferation, contributing to severe inflammation and progression to asthma. Although more research is needed to fully understand mast cell hyperproliferation, inhibiting the surface protein known as MCEMP1 could be a new approach to treating asthma and other inflammatory lung conditions.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Advertising Policy